What is the benefit of PFO closure with a transcatheter device versus warfarin?
In patients 18 to 60 years of age with a nonlacunar ischemic stroke of undetermined cause despite a thorough evaluation and a PFO, the comparative benefit of closure with a transcatheter device versus warfarin is not well established.